rivaroxaban우선순위 중간ICSR 검토체계적 문헌고찰리뷰
LITERATURE DETAIL · PMID 42610841
Reduced Versus Full Lead-In Apixaban or Rivaroxaban in Acute Venous Thromboembolism: A Systematic Review.
Reduced Versus Full Lead-In Apixaban or Rivaroxaban in Acute Venous Thromboembolism: A Systematic Review.
- 저자
- Majed S Al Yami
- 저널
- Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
- 공개일
- 2026 Jan-Dec
- 연구 유형
- 체계적 문헌고찰, 리뷰
- DOI
- 10.1177/10760296261452847
문헌 요약
BackgroundDirect oral anticoagulants (DOACs) are recommended as first-line treatment for acute venous thromboembolism (VTE). The recommended regimen of apixaban and rivaroxaban requires a higher-intensity lead-in phase. However, clinicians may use reduced lead-in strategies due to concerns regarding bleeding risk, planned procedures, or prior parenteral a…
PV 검토 포인트
개별 증례 가능성과 중대성, 예상성 및 중복 여부를 우선 검토합니다.